Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors

被引:9
|
作者
Chen, Xingye [1 ]
Liu, Haichun [1 ]
Xie, Wuchen [1 ]
Yang, Yan [1 ]
Wang, Yuchen [1 ]
Fan, Yuanrong [1 ]
Hua, Yi [1 ]
Zhu, Lu [1 ]
Zhao, Junnan [1 ]
Lu, Tao [1 ,2 ]
Chen, Yadong [1 ]
Zhang, Yanmin [1 ]
机构
[1] China Pharmaceut Univ, Sch Sci, Lab Mol Design & Drug Discovery, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
MOLECULAR DOCKING; DRUG DESIGN; DISCOVERY; POTENT; DERIVATIVES; RECEPTOR; OPTIMIZATION; PERFORMANCE; ALGORITHM; TARGETS;
D O I
10.1021/acs.jcim.9b00684
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein kinases are important drug targets in several therapeutic areas,and structure-based virtual screening (SBVS) is an important strategy in discovering lead compounds for kinase targets. However, there are multiple crystal structures available for each target, and determining which one is the most favorable is a key step in molecular docking for SBVS due to the ligand induce-fit effect. This work aimed to find the most desirable crystal structures for molecular docking by a comprehensive analysis of the protein kinase database which covers 190 different kinases from all eight main kinase families. Through an integrated self-docking and cross-docking evaluation, 86 targets were eventually evaluated on a total of 2608 crystal structures. Results showed that molecular docking has great capability in reproducing conformation of crystallized ligands and for each target, the most favorable crystal structure was selected, and the AGC family outperformed the other family targets based on RMSD comparison. In addition, RMSD values, GlideScore, and corresponding bioactivity data were compared and demonstrated certain relationships. This work provides great convenience for researchers to directly select the optimal crystal structure in SBVS-based kinase drug design and further validates the effectiveness of molecular docking in drug discovery.
引用
收藏
页码:5244 / 5262
页数:19
相关论文
共 50 条
  • [1] Structure-based virtual screening of Src kinase inhibitors
    Lee, Kyungik
    Kim, Jongwoo
    Jeong, Ki-Woong
    Lee, Ki Won
    Lee, Yeonjoo
    Song, Ji Yeon
    Kim, Maeng Sup
    Lee, Gwan Sun
    Kim, Yangmee
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (08) : 3152 - 3161
  • [2] Identification of novel BRAF kinase inhibitors with structure-based virtual screening
    Park, Hwangseo
    Choi, Hwanho
    Hong, Seunghee
    Hong, Sungwoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5753 - 5756
  • [3] Discovery of novel EGFR tyrosine kinase inhibitors by structure-based virtual screening
    Li, Siyuan
    Sun, Xianqiang
    Zhao, Hongli
    Tang, Yun
    Lan, Minbo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 4004 - 4009
  • [4] Structure-Based Virtual Screening of LsrK Kinase Inhibitors to Target Quorum Sensing
    Medarametla, Prasanthi
    Gatta, Viviana
    Kajander, Tommi
    Laitinen, Tuomo
    Tammela, Paeivi
    Poso, Antti
    CHEMMEDCHEM, 2018, 13 (22) : 2400 - 2407
  • [5] Use of structure-based virtual screening in the investigation of novel human sialidase inhibitors
    Magesh, Sadagopan
    Moriya, Setsuko
    Suzuki, Tohru
    Miyagi, Taeko
    Ishida, Hideharu
    Kiso, Makoto
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 (09) : 1273 - 1286
  • [6] Use of structure-based virtual screening in the investigation of novel human sialidase inhibitors
    Sadagopan Magesh
    Setsuko Moriya
    Tohru Suzuki
    Taeko Miyagi
    Hideharu Ishida
    Makoto Kiso
    Medicinal Chemistry Research, 2010, 19 : 1273 - 1286
  • [7] Identification of Novel Protein Kinase Receptor Type 2 Inhibitors Using Pharmacophore and Structure-Based Virtual Screening
    Cruz, Josiane V.
    Neto, Moyses F. A.
    Silva, Luciane B.
    Ramos, Ryan da S.
    Costa, Josivan da S.
    Brasil, Davi S. B.
    Lobato, Cleison C.
    da Costa, Glauber V.
    Bittencourt, Jose Adolfo H. M.
    da Silva, Carlos H. T. P.
    Leite, Franco H. A.
    Santos, Cleydson B. R.
    MOLECULES, 2018, 23 (02):
  • [8] Discovery of a novel protein kinase B inhibitor by structure-based virtual screening
    Medina-Franco, Jose L.
    Giulianotti, Marc A.
    Yu, Yongping
    Shen, Liangliang
    Yao, Libo
    Singh, Narender
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4634 - 4638
  • [9] Identification of Inhibitors of the Tyrosine Kinase c-Met by Structure-Based Virtual Screening
    Lemcke, Thomas
    Dreher, Jan
    Rarey, Matthias
    Totzke, Frank
    Schaechtele, Christoph
    Kubbutat, Michael H. G.
    Kunick, Conrad
    MOLECULAR INFORMATICS, 2011, 30 (2-3) : 145 - 150
  • [10] Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening
    Bajusz, David
    Ferenczy, Gyoergy G.
    Keseru, Gyoergy M.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (01) : 234 - 247